Amir Avan

12.5k citations
344 papers · 9.1k indexed · h-index 50

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
  • Oncology top 1%
    • Cancer Cells and Metastasis

Papers in

    • MicroRNA in disease regulation 38
    • Cancer-related molecular mechanisms research 33
    • Pancreatic and Hepatic Oncology Research 21

Amir Avan

334 papers receiving 9.0k citations

Peers

Amir Avan
Comparison fields: 5 of 163
  • Cancer Research 2.4k
  • Oncology 1.9k
  • Molecular Biology 4.6k
  • Molecular Medicine 279
  • Biological Psychiatry 131
Replace Jack L. Arbiser with:
Jack L. Arbiser United States
Michele Caraglia Italy
Hui Zhang China
Ying Huang United States
Qiang Xu China
Kenneth K. Chan United States
Athanasios G. Papavassiliou Greece
Canhua Huang China
Hisataka Moriwaki Japan
Maria Chiara Maiuri France
Amir Avan relative to Jack L. Arbiser United States Jack L. Arbiser's profile →
Citations per field
00.5×1.5×2.0×
Jack L. Arbiser · 1×
Citations per year

Countries citing papers authored by Amir Avan

Since Specialization
Citations

This map shows the geographic impact of Amir Avan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amir Avan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amir Avan more than expected).

Fields of papers citing papers by Amir Avan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amir Avan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amir Avan. The network helps show where Amir Avan may publish in the future.

Co-authors

The 25 scholars most cited alongside Amir Avan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Amir Avan Line = papers co-authored together Amir Avan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 344 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2017240
2 2019216
3 2017194
4 2016178
5 2019159
6 2015152
7 2018140
8 2017139
9 2017134
10 2017126
11 2018120
12 2017113
13 2016109
14 2015107
15 2018103
16 2017102
17 2018101
18 201797
19 201793
20 201686

About Amir Avan

Amir Avan is a scholar working on Cancer Research, Oncology, Molecular Biology, Pathology and Forensic Medicine and Biotechnology, having authored 344 papers that have together received 9.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (38 papers), Cancer-related molecular mechanisms research (33 papers), Circular RNAs in diseases (25 papers), Pancreatic and Hepatic Oncology Research (21 papers), Adipokines, Inflammation, and Metabolic Diseases (16 papers), Cancer Research and Treatments (15 papers), PI3K/AKT/mTOR signaling in cancer (14 papers) and Epigenetics and DNA Methylation (14 papers). The work is most often cited by research in Cancer Research (2.4k citations), Oncology (1.9k citations), Molecular Biology (4.6k citations), Molecular Medicine (279 citations) and Biological Psychiatry (131 citations). Amir Avan has collaborated with scholars based in Iran, United Kingdom and United States. Frequent co-authors include Seyed Mahdi Hassanian, Gordon A. Ferns, Majid Khazaei, Soodabeh Shahidsales, Afsane Bahrami, Majid Ghayour‐Mobarhan, Mina Maftouh, Mikhail Ryzhikov, Majid Ghayour‐Mobarhan and Farzad Rahmani. Their work appears in journals such as Journal of Cellular Physiology, Journal of Cellular Biochemistry, Current Pharmaceutical Design, Gene and Current Cancer Drug Targets.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026